JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.
Teriflunomide controlled phase 3 MS trials
Several commentators are claiming that any phase 3 trial using teriflunomide as an active comparator are unethical. Before completing this short survey please read the accompany newsletter to get background information on the topic (
click here
).
Sign in to Google
to save your progress.
Learn more
Do you think it is unethical to randomise someone with MS to teriflunomide in a phase 3 clinical trial?
Yes
No
Clear selection
Do you think it is possible to de-risk a teriflunomide-controlled trial for participating subjects?
Yes
Not sure
No
Clear selection
How would you describe your self?
Someone with MS
Family member or friend of someone with MS
Healthcare Professional
Pharmaceutical representative
Someone working for a patient organisation
Other:
Clear selection
Where do you live (county or state and country)
Your answer
Comments
Your answer
Submit
Page 1 of 1
Clear form
Never submit passwords through Google Forms.
This form was created inside of Gavin Giovannoni.
Report Abuse
Forms
